| 000 | 01314 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516063118.0 | ||
| 264 | 0 | _c20120517 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1520-5762 | ||
| 024 | 7 |
_a10.3109/03639045.2011.604327 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOzdemir, Nurten | |
| 245 | 0 | 0 |
_aEnhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. _h[electronic resource] |
| 260 |
_bDrug development and industrial pharmacy _cMar 2012 |
||
| 300 |
_a331-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xchemistry |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aCalorimetry, Differential Scanning |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSpectrophotometry, Infrared |
| 650 | 0 | 4 |
_aSulfamethoxazole _xchemistry |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_abeta-Cyclodextrins _xchemistry |
| 700 | 1 | _aErkin, Jülide | |
| 773 | 0 |
_tDrug development and industrial pharmacy _gvol. 38 _gno. 3 _gp. 331-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03639045.2011.604327 _zAvailable from publisher's website |
| 999 |
_c21289035 _d21289035 |
||